BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 37086063)

  • 41. [Strengthen perioperative multimodality treatment in order to improve long-term outcomes of esophageal cancer].
    Chen KN
    Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Sep; 16(9):811-4. PubMed ID: 24061982
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Current choices and prospects in management of postoperative esophageal cancer patients.
    Tu CC; Hsu PK
    Asian J Surg; 2019 Jan; 42(1):81-84. PubMed ID: 30121147
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The management of locally advanced carcinoma of the oesophagus - SCOPE for improvement?
    Crosby TD; Evans M
    Clin Oncol (R Coll Radiol); 2009 May; 21(4):281-4. PubMed ID: 19223158
    [No Abstract]   [Full Text] [Related]  

  • 44. Combined Modality Therapy for Management of Esophageal Cancer: Current Approach Based on Experiences from East and West.
    Moaven O; Wang TN
    Surg Clin North Am; 2019 Jun; 99(3):479-499. PubMed ID: 31047037
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Influence of Neoadjuvant Therapy on Poor Long-Term Outcomes of Postoperative Complications in Patients with Esophageal Squamous Cell Carcinoma: A Retrospective Cohort Study.
    Takeuchi M; Kawakubo H; Mayanagi S; Irino T; Fukuda K; Nakamura R; Wada N; Takeuchi H; Kitagawa Y
    Ann Surg Oncol; 2019 Jul; 26(7):2081-2089. PubMed ID: 30937664
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Esophageal cancer therapy: a decade of inertia.
    Cohen EE; Vokes EE
    Cancer J; 2001; 7(5):369-71. PubMed ID: 11693893
    [No Abstract]   [Full Text] [Related]  

  • 47. Esophageal carcinoma: current controversial topics.
    Patel M; Ferry K; Franceschi D; Kaklamanos I; Livingstone A; Ardalan B
    Cancer Invest; 2004; 22(6):897-912. PubMed ID: 15641488
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Current status of multimodality therapy for esophageal carcinoma.
    Tak VM; Naunheim KS
    J Surg Res; 2004 Mar; 117(1):22-9. PubMed ID: 15013710
    [No Abstract]   [Full Text] [Related]  

  • 49. [Intra-disciplinary therapy strategy in esophageal carcinoma from a surgical viewpoint].
    Verreet PR; Horstmann O; Röher HD
    Praxis (Bern 1994); 1996 Mar; 85(10):299-302. PubMed ID: 8628958
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Will multimodality therapy solve the enigma of long-term survival for squamous cell carcinoma of the esophagus?
    LoCicero J
    Semin Surg Oncol; 1993; 9(1):14-8. PubMed ID: 8356379
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Effect of thermotherapy on human esophageal carcinoma in culture and clinical cases].
    Shinbo T; Katoh H; Saitoh M; Saitoh T; Shimizu T; Otagri H; Tazawa K; Fujimaki M
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-3):1899-904. PubMed ID: 2730082
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [A pathological study on intraluminal microwave hyperthermia in esophageal carcinoma].
    Qiu SL
    Zhonghua Bing Li Xue Za Zhi; 1985 Jun; 14(2):118-20. PubMed ID: 2935290
    [No Abstract]   [Full Text] [Related]  

  • 53. [Long-term results of the treatment of carcinoma of the hypopharynx and cervical esophagus].
    Okamoto M; Takahashi H; Yao K; Furukawa K
    Nihon Jibiinkoka Gakkai Kaiho; 1988 Sep; 91(9):1375-80. PubMed ID: 3199251
    [No Abstract]   [Full Text] [Related]  

  • 54. Combine radiotherapy and immunotherapy in esophageal squamous cell carcinoma.
    Chen Y; Yu R; Liu Y
    Crit Rev Oncol Hematol; 2023 Oct; 190():104115. PubMed ID: 37633347
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Combined therapy for carcinoma of the esophagus: panacea or puzzle?
    Mountain CF
    Ann Thorac Surg; 1988 Apr; 45(4):353-4. PubMed ID: 3355275
    [No Abstract]   [Full Text] [Related]  

  • 56. Role of Esophageal Metal Stents Placement and Combination Therapy in Inoperable Esophageal Carcinoma: A Systematic Review and Meta-analysis.
    Lai A; Lipka S; Kumar A; Sethi S; Bromberg D; Li N; Shen H; Stefaniwsky L; Brady P
    Dig Dis Sci; 2018 Apr; 63(4):1025-1034. PubMed ID: 29417326
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Optimal treatment for localized esophageal cancer still uncertain.
    Lord RV
    Am J Gastroenterol; 2000 Jan; 95(1):305-7. PubMed ID: 10638607
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Neoadjuvant vs definitive concurrent chemoradiotherapy in locally advanced esophageal squamous cell carcinoma patients.
    Chen CY; Li CC; Chien CR
    World J Surg Oncol; 2018 Jul; 16(1):141. PubMed ID: 30007409
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Discussion of the treatment of esophageal carcinoma,especially in the point of non-surgical treatments, from the viewpoint of medical oncology].
    Maeda Y; Sasaki E; Sasaki T
    Gan To Kagaku Ryoho; 2007 Jun; 34(6):831-5. PubMed ID: 17565242
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Management of esophageal cancer.
    Coia L; Engstrom P; Paul A; Hanks G
    J Clin Oncol; 1990 Jul; 8(7):1285-6. PubMed ID: 2358842
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.